                      0                1                2                       3                 4                       5                6                7                8                       9
             confidence             many               ci                 medical            cohort                  highly              mrr            faced             rate                   model
                 remain        receiving       translated                   focus       susceptible                  sample            daily           factor             show                   among
       immunodeficiency       alveolitis              ass             transmitted               men                category         genotype      replacement           social               infection
              adherence              use            order                      ci              mass                  washer        infection         reported            brief                 service
              tenofovir          service            index              detectable               men                   virus         compared             cell            maker           cerebrospinal
                english     psychosocial            group                     car             cited                  showed          partner           killer       considered                    risk
                   poor             pool        seventeen                commonly      multivariate                     azt       outpatient          patient        challenge                clinical
                     ci          perhaps            among                   daily           without               adherence      spontaneous          primary      development             spontaneous
              infection      endproducts     psychosocial                   rigid              many                    bone            month         practice         decrease              coinfected
        dermatomyositis         efficacy             mass                    cell              late                  opiate      established        glycation              hiv                  stigma
                    std            noted       eosinophil                  person         tenofovir          antiretroviral         pathogen         abstract        phenotype             reinfection
                measure             drug       individual                disorder              user                proximal      multicenter        determine       decreasing                     hdl
        methamphetamine        adherence    investigation                   serum      longitudinal                 barrier           higher           living         efficacy              alteration
                     ci         survival           effect                  method             daily                 patient         discrete    questionnaire            among                   major
            combination            hdlox           random             measurement         influence                 inverse         practice immunodeficiency       resistance                   human
        bronchoalveolar              rna         evidence                disorder              idus                 patient         presence         suggests            group                presence
                  score        treatment         analysis                 testing               age                    load          barrier        increased          chronic                  showed
           introduction         receptor          patient          rehabilitation               hcv            occupational        hepatitis      furthermore           condom                antibody
               increase   neurocognitive          finding                promotes      particularly                   april           sexual        injecting           person               injecting
               injected         promotes       prostitute                 rapidly        alteration               injection         positive        seventeen      information                 english
               improved       retroviral            count                antibody       combination                   fluid              ass          examine      interaction               treatment
                    gay        indicated              hiv                clinical               age               clearance       evaluation       prostitute         alveolar                  opiate
                  group          quality             good                   fluid           kismayo                 steroid     multivariate          patient           unsafe                  muscle
              conducted        predictor            first             responsible             rural              identified            viral      development       identified                     hcv
       immunodeficiency           unsafe           school                 kismayo             total                    ptfe             also     pathogenesis            viral                   swiss
                    bal         commonly         periodic           epidemiologic          receptor                   group          measure       homosexual              art               expressed
                 cohort        injection        treatment                    area        population             significant          article      distinctive       alveolitis                     hdl
           monoinfected            trial             data               adherence         injection                   death         bisexual              hiv         myopathy                  larger
                   drug       prostitute        influence                   study        evaluation             significant         previous            viral             high                  number
           presentation              azt        dimension                 earlier            plasma                    beta           member           thirst       alveolitis            osteoporosis
               advanced            count            srage                injected             count                positive     quantifiable        adherence             role              eosinophil
            responsible          natural             ivda                     hcv             among            asymptomatic            among            liver           unsafe                     use
                clearer         sexually         reported                 patient         injecting                  little           policy              hiv        ethnicity                measured
             containing        elevation         genotype                      ci         underwent               resistant              bal              hiv              hcv                  survey
       immunodeficiency         majority              rna                analysis             month                analysis              due          control            adult              disoproxil
              operation          chronic     monoinfected                  likely        thrombosis                     ass              one          perhaps              bal                     art
                  liver             died         positive                infected         procedure                     new          overall       infectious            abuse              coinfected
               negative        presenter         dialysis                 leprosy         described               interview           person           little          partner               secondary
             associated        mortality              hiv                  survey       progression                  likely         combined         assessed          fistula                 finding
                    hiv         reported            hdlox              difference          previous                   among           others          partner    observational                   virus
             comparison          patient            month             spontaneous             rural                    host        objective              aid           mental             schistosome
                  count             mass        interview             chronically          mandarin                   among      schistosoma              age            patch              comparison
              glycation         alveolar         southern                      mg    absorptiometry                     age            virus              art         baseline              prostitute
               receptor        conducted           heroin              translated          regional                 ability        conducted       optimizing              csf                   heavy
                 hunger             cell         commonly              individual         adherence                southern           biopsy           member        morbidity                 perhaps
                placebo              use           median                infected              mean              evaluation             dali          greater            virus                 partner
               starting              hiv          therapy                 patient             count                   hdlox            liver      suppression        mortality                     bal
               elevated            haart         moreover                  tissue             order                pathogen              hdl          article           sexual                explored
                  among            month           median                   merka       reinfection               mortality           change            srage            group                 outcome
           longitudinal           danish        emotional                   fluid            course                   virus      schistosome         advanced              ige                 contact
              glycation  retrospectively           muscle                    risk            number                    drug       peripheral       laboratory             beta              uninfected
                 factor            among     introduction              associated           patient                  family             camp            graft            count                  factor
            association      schistosome      maintaining                  always           overall              evaluation             late       population             good                analysis
                 washer             mode      furthermore                     one         dimension                   graft          disease          barrier        including                   range
               syndrome            human            index            complication             viral                cercaria            graft              hiv              ige                   china
                  first      generalized             drug                   focus  immunodeficiency               hepatitis          optimal   antiretroviral           member               treatment
               antibody      endproducts        presenter                  likely               csf                esoteric          sibling           status             care                modulate
                 subset             also         analysis          antiretroviral               hiv                   first       individual        treatment           muscle               seventeen
              presented         infected        treatment                  ¦Ähdlox         predictor                   adult           factor            model          chronic                    year
          questionnaire           ¦Ähdlox        adherence               hepatitis         guideline                    ivdu        including         changing     testosterone                practice
             individual            graft        implicate                     men           patient                efficacy              bmd        injecting             risk                   among
             proportion        challenge         esoteric                   score         procedure                 history          symptom           sexual             camp                  little
         absorptiometry            guide        determine               mortality             human               adherence          however        oxidation            china              uninfected
             nongenital          service       coinfected                  washer           patient                 finding         myositis           sought           sample                  linked
               elevated         injected           sexual               available               due                     hcv          despite       translated             beta                     men
                     mg              azt     multivariate                   swiss         receiving            complication              bal         acquired     osteoporosis                 fistula
            independent           faster   immunoglobulin                presence            review             schistosome            first           faster           danish                 natural
                   male         measured             well                    cell              idus                   serum           median             care         increase              limitation
           respectively             year            score                      mg        concerning             spontaneous immunodeficiency             life        described                immunity
                however             year             blot                     hcv              cell                positive         bisexual   antiretroviral        including                   focus
         susceptibility          patient         function                  higher          positive                   maker      fcepsilonri             many             late               infection
            reinfection     hypogonadism         alveolar            demonstrated              drug                analysis        tenofovir           effect          western                 mineral
              presenter          greater        treatment                    risk        prevalence                 overall        suggested           faster        glycation                advanced
                   pool             bone           change                     snp        prevalence               infection           little            death             load                  unsafe
                utility        injection           change                      le               use                  thirst         proximal     tolerability              may                     age
         neurocognitive              hiv       peripheral polytetrafluoroethylene               age                   patch        sustained          however            viral                  survey
                  group              aim       percentage                  likely         effective                infected              csf          patient          capital              prognostic
                  srage   antiretroviral   antiretroviral                  strong        detectable                     bmd        treatment         clinical       disoproxil                 subject
             associated     multivariate             five                occurred    antiretroviral                    data            human     multivariate             role                  muscle
                   long         provider       prevalence                 overall        moderately                 patient           former            liver              rna                 patient
                 either            virus        treatment                    data         tenofovir                suggests              gay   antiretroviral            virus                     csf
                  enter          kismayo       optimizing                genotype           whether                  killer            maker      combination            focus                 measure
                   week             camp           others               mortality         underwent                genotype         efficacy         clinical     eosinophilia                    also
                 status     eosinophilia          natural                 suggest             count                    male             body              hiv       resistance               suggested
                patient          however         assessed              protective      undetectable                    cell              bad      intravenous     tolerability                  biopsy
                disease            event         previous              translated         hepatitis                 chronic      abnormality          natural       associated                    odds
                finding        responded           remain               presented           earlier                    mass      intercourse          however             type                  strain
               assessed        increased               df                    beta            esrage             interaction        discussed        determine            study                   hdlox
                percent          chronic         starting                     csf           therapy                provider               ci        adherence            count                   order
                   ivdu            eight      formulating                sexually               cvd            testosterone        implicate              art      schistosoma                   patch
                    age       associated            least                     rna             aware                   among           stable           policy          support              increasing
              glycation           condom        increased           multivariable               pwh                    bone        collected        injection        conducted                    bone
                     ci   rehabilitation     lymphotropic                     bal         indicated                      mo            major             data             city              protective
              receiving       persistent         genotype                   among              week               completed       durability          primary              ass                suggests
          significantly        tenofovir          finding                starting        peripheral                  change       individual              may           unsafe              individual
                  among     representing             user                     rna            health                  stigma          subject           muscle          present                   rigid
               function        developed       individual             multicenter        limitation                   among           esrage        challenge         pharmacy                    lean
                perhaps   antiretroviral         survival                  sexual                df            psychosocial             risk              hiv           remain                     hdl
                    bmd            april              men                genotype            ¦Ähdlox             reliability      coinfection         isolated               nk                   among
                   form        expressed        developed                  taking               hiv                 improve  atherosclerotic       occasional           median                    drug
           monoinfected          unclear      reinfection                    cell               hiv                 optimal       detectable            focus          however                   using
           introduction              hcv   antiretroviral                  scored seroepidemiologic           psychological         mandarin           killer       covariates            monoinfected
         antiretroviral           taking            known                  person               may                  change        injection           kenyan            enter                   haart
                    bal        injection   antiretroviral                  health       experienced                 regimen         dialysis       cumulative            urban                compared
                   loss              hcv        responded                   merka             among                   group         reported             cell           higher                interval
                    azt           likely           policy                fumarate             virus                   among         function              aim             role              uninfected
               previous           stress        clearance          azidothymidine           product               dimension           likely       confidence      schistosome                   adult
                suggest       population   antiretroviral             development       involvement                included             mass             data           change                 contact
                 health        underwent            level                 partner            school                     men        situation          suggest       detectable              evaluation
                    rna               mg              hiv                 disease               low                  sydney             drug             mass             show                    role
              therefore              low          therapy                  factor              week                   focus   antiretroviral        including         promotes                 chronic
                    hcv        responder       protective                 include         clinician                greatest     relationship              red             rate               community
                   care              may           highly               oxidation    antiretroviral                  sexual            daily coadministration       critically             maintaining
            prospective           impact            ratio                compared            within                 barrier       prostitute       thrombosis      requirement                   study
                    hcv             blot    hydroperoxide               infection          function                promotes           remain             type        sustained              eosinophil
                   beta     representing         greatest               interview             group                compared        glycation            first        injecting                  impact
           inflammatory      spontaneous        emotional                fumarate             cited                analysis       associated      measurement          disease                    show
                    use       associated         reported                  taking           disease               prognosis            group               mo            human                starting
                therapy              rna             cell               phenotype         expanding                  result             cell            prior       associated                     six
                    hdl          service           faster                 english           finding          characteristic           stigma           higher            among                     gay
                 survey     testosterone         baseline              medication        correlated                    male          primary          utility              men                baseline
              evaluated             ptfe       persistent                     mrr                df                   swiss         included               ci          therapy                   faced
                ability              hcv        responder                sexually            survey                  social          optimal        indicated            serum                  family
        methamphetamine              hiv           female              prostitute          strength                    drug            among               ny           muscle              population
                    pwh     polymorphism           living                     cvd        understand             schistosome          therapy               df     particularly                      le
                  adult          related           likely                     azt               azt              regression       eosinophil         increase        decreased                     rna
                  viral              cvd       univariate              eosinophil           finding              considered          success       confidence       consistent                presence
                 living    significantly         combined                   group              test               inventory       persistent      circulating           change                     hdl
                   year              use             drug                     age            effort                  esrage        secondary             pwas        implicate                   index
                    hcv            virus             risk                     snp             faced               influence            group              hiv            focus                    need
             nongenital            study         majority                   sleep         expressed                  effect    cerebrospinal          placebo             rash                   virus
               molecule             high     relationship             combination                ii                 therapy           gender           effect         presence              persistent
               presence          concern         clinical                    ivdu            change                    week           taking           strain            noted                    drug
                  heavy         esoteric       medication                antibody               std            inflammatory          optimal      experienced          ¦Äesrage               treatment
                   user             rate        suggested                molecule            result            southwestern              may            hdlox       comparison               injecting
                    men             town       uninfected              moderately             level                  within           esrage        sustained        treatment               conducted
                    rna           member     inflammatory                     cox              year                  hunger    multivariable     longitudinal      requirement                 mansoni
                    men           factor      responsible               effective               hiv                moreover          surgery     transmission         qoryoley                 patient
               suggests              hcv             data             lipoprotein            people             endproducts             idus           inject           number                  sexual
            abnormality            cited              gay                   focus              risk         bronchoalveolar          whereas      endproducts              rna                  effect
                   drug            urban           access                baseline           optimal                 disease      significant              one         physical             abnormality
                    use      requirement             care                 feeling        infectious              comparison          emerged   susceptibility       predicting                     hiv
               exposure          patient           change               increased             ¦Ärage                    play            first immunodeficiency             town                  ¦Ähdlox
               positive             bone          utility           hydroperoxide           english                utilized          patient       individual          placebo                  factor
              injecting           living             risk                     std       circulating                 mineral           former           others         reported              prevalence
                 health           likely           former              especially          infected                previous       disoproxil        adherence           sexual                detailed
              effective             year            score                baseline       coinfection                     rna      spontaneous       comparison           sexual                survival
            involvement           scored       containing             transmitted           history                   fluid               nk         clinical          optimal                  needed
               discrete       associated            brief                    risk        comparison                 natural               le          perhaps        selection                   adult
                    due             rate             camp                    well    neurocognitive                   ratio          barrier           factor     investigated                    form
                 median            month       consistent                     hcv  coadministration                southern        infection          steroid        selection                     new
           monoinfected         interval           within              eosinophil              bone                    late     presentation         mandarin          regimen           epidemiologic
                 active          subject           family                  ¦Ähdlox           control                    cell              hcv       contribute        treatment                   owing
                 former             late       prevalence                  health             brief                 symptom           member            virus        normative                interval
                  study     multivariate      reinfection               infection             among        coadministration      intercourse       identified              hcv         methamphetamine
             consistent immunodeficiency        oxidation                      yr               bal                  policy          overall            hdlox           survey                     hcv
                 member             data            first                    odds                df                clinical        adherence          greater             lead              containing
              clinician    psychological              azt                     hcv               ass                infected          partner         genotype           sexual                  muscle
                   mode            owing           health              medication         suggested                  heroin              bmd             city        ethnicity               adherence
              mortality           lavage          history                function               men             combination        tenofovir           biopsy           little                  health
             regression        collected          overall                  remain  immunodeficiency               glycation       percentage         disorder          patient                    need
              effective            rural             load                     use               pyr               glycation         weakness              sex      maintaining             contributes
                   drug            count           condom                  unsafe               red                      ci        decreased          barrier        injection              hypothesis
                   cell             body        mortality            tuberculosis        coinfected                utilized         genotype          perhaps           number             suppression
                 likely          routine          antigen                 cleared         sustained              medication       detectable              men     particularly                    data
              elevation              six           within                function            impact                   noted      generalized        responded            issue                  change
           particularly        community          patient                    male  immunodeficiency              individual       introduced          overall            graft             qualitative
                   test          subject       associated                  opiate              late                  higher       peripheral           muscle            death           understanding
                 member       outpatient         pathogen             circulating         including            investigated              csf        collected     transmission                    beta
                  among immunodeficiency  retrospectively                    mass              risk               treatment       treponemal      progression           taking                 subject
                  brief         bisexual          disease                 capital       multicenter                   major        tenofovir        mortality         discrete              moderately
              adherence     tuberculosis            human                 barrier        prognostic                   hdlox            heavy   antiretroviral           survey            inflammatory
            fcepsilonri         baseline             lean                     rna              lead               increased              aid         efficacy          overall                 cleared
               distress      chronically       optimizing                    word               end                 engaged             rash         economic             lead                    ivda
              reduction       concerning          placebo             suppression           chronic                     hcv              car      spontaneous       decreasing                  highly
                 family             lead         strength                 predict        prostitute                reported         dialysis          patient               le               determine
                patient          overall        adherence                   haart         collected                 routine           policy              hiv           member                fumarate
                therapy             mean        collected            investigated         reporting              correlated         obtained      interaction       ambulatory               secondary
                   ivda        tenofovir             poor              clinically           capital                    cell              hiv         cercaria immunodeficiency               oxidation
            morphologic            study           living              employment    antiretroviral                 mineral       associated        treatment              aim                  effort
                    bal        elevation              hcv                  partly         informant                practice       infiltrate         conflict      progression             antioxidant
                 cohort       contribute              csf               addiction        decreasing              associated             harm        hepatitis           highly                    drug
                    gay          disease             bone              considered               art          reconstruction        addiction          patient           member                  higher
                   rate         compared             mean                  little            impact                     rna        infection        completed             week            relationship
              emotional              new        reduction                analysis            unsafe                    drug          picture          symptom           partly                 primary
          investigation              bal            patch                   study    antiretroviral             abnormality        injecting              men         practice                  muscle
                  graft         estimate        injecting                  number          survival                   first          history         advanced          chronic                 primary
               presence      significant            party                    cell           concern                     aid             test            level  dermatomyositis                 chronic
      seroepidemiologic       especially           factor                  condom        population                  strong       infectious        adherence           scored                     hdl
           tolerability              hiv              rna                   chain              week                     men      progression          partner        increased             experienced
                    hiv  differentiation               mo                   range           patient                     age              bmd         syndrome        treatment                 gleaned
              including     tolerability             week                     hcv      lymphotropic                increase           esrage      suppression          perhaps                 engaged
              collected          partner           remain                  faster        prevalence              registered      independent           stable          intense              considered
                    age           scored          patency           cerebrospinal               hiv                  survey            rigid            acute          fistula          cardiovascular
                   bone             said          unknown                   study               bmd                 surgery           potent             well           taking           epidemiologic
             resistance          barrier          patient                   human          negative              prevalence             drug               nk             data               infection
                    azt       concerning       employment                  unsafe              ivdu                  common               df            liver           condom              frequently
                  major           inject      abnormality                  stable         adherence                   group           stable            study             pwas                    high
                kismayo  retrospectively             body                infected        individual                 history     multivariate     demonstrated        clearance               responder
             regression            haart             rate              correlated              show                 examine          success         assessed           change                   graft
                  level      suppression             rate              confidence              body               conducted              aid          whether              hiv                  review
                    age          barrier           killer                 concern       spontaneous                    drug        available        treatment        therefore             circumcised
                patient       comparison              pwh                     low        evaluation              coinfected          surgery    cerebrospinal        describes                 however
                    hdl         exposure           either                southern          presence                 partner        tenofovir             ptfe     presentation                  washer
                  model          improve           parent                     low              long        immunodeficiency             ptfe            order      association                alveolar
                  merka              due         increase                 therapy          positive                   virus          history              car       nationwide               available
              collected           remain           number               ethiopian          promotes               injecting         previous              hcv            hdlox                 measure
               injected         previous             cell                  gender           symptom                    drug        adherence           access           immune                   focus
                 member     introduction         relevant                     azt          employed                   guide              cvd     particularly       resistance                   among
                partner            human       introduced            osteoporosis         estimated              prostitute         targeted             drug      interaction                utilized
              presenter              hcv         impaired                 service               pyr                negative            woman             care              rna                     bal
                   risk          however              one                     key               azt                qoryoley           unsafe        tenofovir           always               injection
         reconstruction       deficiency          disease                  island        consistent                  adhere           faster           member       persistent                     hcv
             identified            study            adult                   total         ethnicity              comparison        clearance              hcv            hdlox              associated
                   year         proximal           sydney             progression          exposure                   month            daily             york          patient                    rate
                 common              gay          without               influence             level                 suggest             play          service              hiv                provider
                quality      significant        objective                  common            factor                     idu            haart           likely         practice                    five
                    hiv     investigated        mortality                 finding             focus            hypogonadism              hcv            swiss          placebo                    ivda
                     nk           refill            study               interview             using               treatment         analysis         achieved           people               injecting
                     ci       deficiency       uninfected           cerebrospinal        persistent                 examine           living            total       comparison                  washer
                  count      probability          opposed               prevalent        comparison            presentation         infected            maker             role                  impact
               combined         presence      reliability               injecting              year                  parent              bmd           impact              art                     bad
                    low              pyr            would          neurocognitive           measure            undetectable           change     undetectable         randomly                   total
            endproducts              end         baseline                function     significantly                      df        adherence       medication        influence             chronically
             confidence     monoinfected         obtained                question                ci                   haart       prognostic        injecting      participant                  refill
                  hdlox           likely         cercaria                  factor           without                     azt           either           tissue       especially                received
                   lean           sexual           either                 subject         sensitive                      ci          without         frequent          patient                     hiv
                antigen         majority         improved                 outcome        individual                    male              hdl        presented            virus               inventory
                 subset    psychological              hcv              disoproxil            female                  likely          perhaps        correlate             many                  washer
                   skin           survey         antibody                  person             virus                   human             risk             harm     longitudinal                  sexual
              mortality            fluid             rate              frequently              none                   level        treatment          primary            among          immunoglobulin
                   ivda              azt              hdl                  number               gay                     two           condom         compared         esoteric               prevalent
                  human             year        clearance              medication            washer                clinical          ¦Äesrage               ci           immune                efficacy
           inflammatory           number       autogenous                   known             human                  likely              low          mineral              hiv                   level
                however      circulating              hdl       electromyographic        thrombosis                designed         disorder         starting        mortality                   serum
                   late            issue              use                  unsafe            lavage                  former        mortality        determine        injecting                  kenyan
                patient          unclear            serum                    well            muscle                    mass       deficiency         examined       detectable                previous
                  srage       frequently          dietary                economic        employment                discrete     particularly          regimen             data                immunity
                perhaps        treatment            month              individual               snp           psychological        underwent       laboratory           potent          antiretroviral
                 little          symptom          service                occurred          relevant              detectable              azt         relevant         increase                    cell
              responder     monoinfected        adherence                   graft   methamphetamine              associated          develop          cleared       associated                 regimen
           demonstrated        indicated           impact                    test            social              comparison           immune         alveolar              rna                    drug
               alveolar         promotes           family              coinfected     significantly               indicated            lipid           sexual            acute                physical
               alveolar       retroviral        elevation                increase           patient               morbidity           stigma           status        injecting                 optimal
                    sex          soluble             user                majority          function                 disease        objective             well     inflammatory              introduced
             endogenous       coinfected       comparison                   would                df                 barrier       individual            focus          however             information
                    gay     osteoporosis        potential                reported       implication                  stable           family        hepatitis        glycation                distress
                  count       prevalence        responder                  people              late                    late           taking            model            issue                    show
                   late       undergoing      formulating              confidence         reduction           observational            adult             news               df              translated
                however            human              bmd                  effect        thrombosis                presence             body         infected             male             intercourse
                    csf          problem           effect             contracting              time                     new              hcv          steroid           factor                    skin
                 number          partner        glycation              difference          baseline                    lead             bone           family        hepatitis                  linked
                  count              azt         baseline                fumarate  coadministration                  opiate        reporting          therapy             beta                   liver
             descending       coinfected             mass                  policy            unsafe               treatment          density          disease            haart              increasing
                 sexual            study         utilized                   hdlox         discussed              identified immunodeficiency immunodeficiency             user                    bone
              infection              azt            ratio             intercourse               hdl                distress         clinical              hcv            brief              individual
                  model             rash              use               challenge      characterize                    used         computed             week     tolerability                 without
                    bmd       critically          steroid                 service          dialysis                     hcv            virus   neurocognitive            owing              coinfected
                therapy          sibling       frequently                  survey               hcv               injection              hiv       population        treponema                although
                 status              pwh         exposure              uninfected        percentage                   would        dimension           parent         qoryoley                   aware
              infection            rigid             show            pathogenesis           unknown                     new            focus          disease            china              univariate
                 gender       detectable            among                syndrome              rate             schistosome           method          kismayo             care                     hcv
                    pwh          patient         periodic                     hcv            muscle                     may              hdl        clearance             five                baseline
             resistance      fcepsilonri           plasma                     pwh            effect              univariate         majority immunodeficiency             pwas                  factor
               reported              hcv           mental                   cited     observational            transmission         acquired            month         practice                  health
                 factor          however             body             reinfection             noted                analysis           effect           change             host            inflammatory
                engaged           unsafe              gay              autogenous          occurred                     std           course          perhaps           factor                     std
                   town        adherence        injecting                 gleaned       biochemical                   virus              red            virus          history              consistent
               utilized         practice              bal                     idu            somali               receiving          service           sexual       resistance                 patient
           tuberculosis          perhaps          english                  effect        endogenous                   woman             care        informant       prevalence                  system
                   drug           heroin          natural                      df           soluble                  member         syndrome            hdlox              men                function
             percentage            group             late                   known       intercourse              associated         southern       macrophage   susceptibility              medication
             identified             late              art                   noted           fistula               underwent         greatest         reported immunophenotypic                  sexual
                     ci              ass        including                   blood        descending                   first        glycation         discrete          subject              nationwide
                    hiv       neutrophil          gleaned                 therapy         increased              occasional        determine             late              hcv                  kenyan
              adherence         regional           sexual                efficacy            effort              translated             test           change           either                 mineral
                overall           opiate         moreover                   group              odds                     car        elevation             skin             ivdu               decreased
               provider         alveolar         analysis                   study           content                  muscle             drug        adherence              csf                   acute
                  count           muscle             week                    beta             month                   alone            major             idus         receptor                estimate
                  eight            study        presenter                     ige            result                  thirst              hiv          dietary              low                 therapy
               alveolar         reported              men                     hiv             rural                      ci            hdlox            ratio       containing                   serum
                  death     hospitalized         receptor                   china            family               seventeen             load              rna             mass                    many
            reliability           remain      schistosoma                 service         immigrant              coinfected     polymorphism      coinfection            major                   serum
                 within       associated              car                 primary           hundred                   group          regimen       resistance           sexual                      cc
                 number       negligible        including             suppression           several                    drug         majority       population            owing                 product
        supplementation         alveolar         economic               clearance               hcv                  ¦Ähdlox           effect           stigma immunodeficiency                mandarin
              determine           somali       eosinophil                  health          explored                distress           unsafe        treatment          barrier                exposure
               starting      distinctive          examine        immunodeficiency           content                    show          chinese             mass             also                   trial
                 number          intense       hypothesis                revealed      tolerability                  change          reduced          patient         function                research
                overall          include           median            asymptomatic        associated          neurocognitive              men        correlate        preceding               immigrant
          hydroperoxide            viral          earlier                assessed           natural                     bal          concern       individual     metropolitan                 disease
            schistosoma            virus         occurred             antioxidant  immunodeficiency                     gay           island           always          patient                     rna
                overall            count            death                      df    susceptibility                    user            group        influence       evaluation              individual
                testing           active             rate             reinfection          regional              prostitute           sought           sexual      spontaneous             circulating
                  index        important       infectious                analyzed            muscle                   count          release           either            total              eosinophil
                  range      fcepsilonri            woman            metropolitan               age            osteoporosis           lavage             mass          picture                 disease
               function          optimal           living                   woman           younger                    drug        treatment       retroviral            viral                    role
           relationship      fcepsilonri            count                  social          weakness                    lead           partly           unsafe           within             information
             prostitute           mental      association                   urban           patency                  esrage              rna        preceding       eosinophil                    play
             expression              age         infected            complication           chronic               evaluated         provider            ratio          cleared              contribute
         rehabilitation            death       deficiency                   major               hcv                  little              hcv       endogenous        treatment                  larger
          epidemiologic           highly       government               collected              camp                   serum            swiss          symptom             used                 therapy
             resistance             loss             risk                   urban             level               describes         genotype        glycation    cerebrospinal                 chronic
                leprosy            cited           linked                     bmd       combination                occurred            woman          regimen         periodic               treatment
       coadministration          density              use                     ass              week              prostitute            first         myopathy           higher              retroviral
                  heavy        effective     asymptomatic                   hdlox            sexual               indicated       descending        guideline             lead                     red
              potential            owing             mean                    bone         infection              occasional      independent              csf             risk               presented
                 parent            owing           refill                   count            period                    town             died           likely    significantly                    drug
              androderm               le             cell                genotype      eosinophilia                  member             role        australia           effort                     azt
                 muscle         syndrome           family                 patient               azt                     hcv           median        addiction       identified                      cc
               compared            fluid        informant               indicated        alveolitis              cumulative          testing   reconstruction      abnormality                   entry
           tuberculosis             risk       medication               implicate       composition               glycation         previous        truncated           change                mandarin
                 random          symptom        potential                   group           improve               normative          optimal         efficacy              use                 capital
                 either        responded            prior                commonly               snp                     idu      spontaneous              pwh   antiretroviral            undetectable
                    ass      suppression        operation                     art              lead              peripheral   antiretroviral          chronic      furthermore                   human
                 killer       individual   characteristic           significantly          explored                     due   azidothymidine             ivda          steroid          cardiovascular
                 random           family            china               potential              five                 subject    significantly          utility           yearly                   human
              potential           killer              use                 patient              show                proximal        receiving            virus       homosexual               elevation
               distress  retrospectively              cvd                 symptom            stigma                analyzed         reported         reported         antibody                    role
                  virus        infection           yearly                     pwh         secretory                   daily       persistent             mean           change                   serum
              adherence           effect         myopathy        immunophenotypic              lean                    week    cerebrospinal          regimen     intervention                  immune
                   rate          unknown     particularly                     hcv            policy                   entry       associated          partner        mortality                 medical
                sibling          patient              low                     hiv      characterize               suggested            maker             word            graft               seventeen
               reported         analysis           common              neutrophil        frequently                   total              pwh           sought      abnormality               predictor
              injecting            human             camp                     hiv              cell                    test        truncated          present          capital                 overall
               clinical           higher         reported                  within       development                     ass           either       ambulatory        sensitive             prospective
          physiological         genotype            daily                  course               rna                     snp           remain              car     testosterone                pallidum
                  graft              csf        receiving                 provide            refill       seroepidemiologic           dosage         myopathy       respondent               treatment
                   idus         immunity        glycation             schistosome            esrage                  parent             type             load             bone               glycation
                 course         alveolar      antioxidant                     may       suppression                    drug              hcv            count        objective                    show
              including         achieved           plasma               describes            condom             schistosome             cell          unclear        including             progression
            development         promotes      established                occurred     psychological                 therapy          however            graft            found          antiretroviral
                   harm       predictive           gender            particularly         injecting              medication           condom           active        treatment         atherosclerotic
            schistosoma         proximal            among                    data            factor             established              hcv          routine           factor                relevant
            reliability          patient            viral          rehabilitation            inject                 several         logistic         combined          partner               addiction
                therapy              men          symptom                   major         estimated               presenter           people    opportunistic            blood                    data
               isolated          inverse           member                    need              male              identified             mass          intense           school                 history
                  total            blood             type                    mean          presence             coinfection        clearance          mineral              rna                elevated
                history             week         baseline                   ¦Ärage           service                modulate          failure          perhaps     presentation               conducted
          significantly           sexual            virus              correlated          estimate                impaired         research               mg            group                improved
                 opiate           sexual          regimen               australia              week             intercourse       retroviral            viral        sustained               injection
                    men    questionnaire             cell               proactive               new                   graft            level       comparison         compared                   trial
                   rate         impaired          routine                  higher              bone                commonly          natural immunodeficiency           likely              associated
                   week              bal            chain            inflammatory       multicenter              individual              azt          sibling          placebo                     men
                  found   antiretroviral       concerning          neurocognitive     psychological                starting        mortality          feeling       medication                     men
                  count               nk       prostitute               objective    rehabilitation                    many            virus           muscle            death               suggested
                  among         antibody           active             participant          commonly                positive        sustained         presence        decreased                    pool
                 median           common         regional                increase          severity        immunodeficiency     presentation        receiving            human                 mineral
                    art          quality             free               estimated             haart                     hcv      contracting              men            srage                myositis
               promotes          regimen    cerebrospinal                economic           finding             lipoprotein              age           living           ¦Ähdlox                     gay
                  daily           washer         baseline                 perhaps           picture                  factor         analysis              bal         alveolar              negligible
                   beta     undetectable      development            polymorphism         preceding              persistent         commonly           family              men                  sexual
                    pyr       prevalence        australia                  sample         described                 therapy         analysis     monoinfected             late                     low
                 cohort         reported              gay             qualitative               aid            eosinophilia           member       thrombosis        suggested                    late
          cerebrospinal     representing         alveolar                   fluid            opiate                pathogen            study      preexisting         practice                    news
                 median        oxidation          utility                 antigen               two               infection          patient          outcome   antiretroviral                   issue
                    use         elevated             data        immunodeficiency            family                 support           washer           dosage        procedure                periodic
               efficacy        developed         clinical               treatment         objective                 intense immunodeficiency       identified           parent                starting
                     ci     monoinfected           opiate                  effort          relevant              expression          contact         immunity            human                    used
                  patch           change       prostitute                     std         mortality                     hcv       alteration         pallidum          failure             circulating
               reported         cercaria           potent                 unclear            little                     cox         regional            acute       individual                  change
             prevalence         infected immunodeficiency            pathogenesis        difference                   major        occlusion        glycation             rash                   trial
                   drug           mental             blot                     hcv       susceptible                  living        mortality           better              bal                    mass
                   idus           strain          history                 dietary    antiretroviral            testosterone        including         presence             care                    cell
             clinically            eight       resistance                    drug                cc                   study            stage     investigated       uninfected                     hcv
             prostitute        expressed              std                    cell            island                survival             ptfe     tuberculosis        challenge               normative
             persistent            serum   cardiovascular          characteristic      monoinfected                 history            first          gleaned             side               infection
                mansoni       comparison         behavior                  sexual          greatest              retroviral            count            among          partner                    late
          epidemiologic      implication    opportunistic                 patient           patient               immigrant         category         starting             late                   blood
            multicenter          without       negligible                 earlier             count                   virus          steroid             bone   reconstruction                    drug
              adherence          soluble          patient              difference            health                 therapy             drug        glycation          sibling                efficacy
               alveolar         regional       consistent                    week              year                 antigen           lavage       associated             week                 patient
              injecting         alveolar              men                promotes              said               guideline        developed            among            graft               glycation
                   dual               ci         exposure                bisexual            mental              considered        conducted              may           weight               oxidation
               distress         interval       limitation                function         morbidity              associated       associated            serum              cvd            undetectable
               pallidum             drug        preceding                    skin           patient            complication        infection      experienced           strain              eosinophil
               modulate           faster       individual                    risk          economic                   china        influence       disoproxil             lean                  stable
                    use             free            graft             progression              cell                 finding      spontaneous          without       increasing                   aware
             hypothesis           impact   immunoglobulin                   china               men              clinically           living              hcv              men                practice
                 tissue        secondary          perhaps                 patient        difference                     ige              art         bisexual             week               adherence
                natural immunodeficiency           remain                     hcv          infected                 however          percent     polymorphism          regimen              coinfected
                picture             care         explored                      ci       replacement              associated        occlusion       individual            hdlox                    ivdu
               clinical               nk            ¦Ärage             circumcised              male                 patient             well               ci      significant               phenotype
                 person            virus            study                positive       biochemical               immigrant    opportunistic       medication           potent              associated
                 course             male            level                baseline                nk              neutrophil              use          limited             said                     two
               research         receptor          subject                     bal             group               glycation        secondary        reporting          regimen                bisexual
           testosterone        ethiopian          history                  opiate               hcv                  survey        adherence       clinically        described                    drug
                   ivda           mental      susceptible                  review             first                presence         physical       difference          disease                     men
              informant       associated          symptom                  immune          baseline                    harm       containing            human           member               glycation
           intervention       consistent     presentation                  weight          assessed polytetrafluoroethylene       occasional            virus           ¦Ähdlox               oxidation
               alveolar         qoryoley         positive                although         presenter                    camp          patient             risk              men                     hcv
                    mrr      intercourse             drug             spontaneous            adhere                   human            blood         research         esoteric                analyzed
                  count           member          disease             abnormality        evaluation                 barrier            group           period            virus             furthermore
           monoinfected            haart         practice       electromyographic                cc                   death           subset             type         baseline                 related
                    hiv         positive       percentage                compared       chronically          antiretroviral            prior            study       associated              individual
       immunodeficiency          cleared       contribute                      nk         effective              hypothesis           remain            fluid       clinically                  status
                   load        determine          primary                    type              late              correlated             town           course              rna                 ability
                    hdl     testosterone         commonly                 placebo    antiretroviral                 require           muscle             cell         analysis                  health
       immunodeficiency         category             lean                   hdlox             patch               frequency              hcv           taking           status              decreasing
               survival               cc             cell             association            factor               procedure          patient  dermatomyositis        indicated                   haart
                   host          barrier            level            presentation            stress            complication         positive         research           survey                      ci
                   bone        interview              bmd                baseline               hdl                   virus        conducted              hiv           either                     mrr
                 survey         disorder             week                    cell       transmitted               influence       predictive             bone    significantly                dialysis
              australia             five            acute                pallidum        eosinophil          antiretroviral            blood           little         computed               collected
                 survey             well         analysis                reported               bmd                      mg        responded        responded       resistance                 natural
              morbidity           larger         fumarate           questionnaire             rural            eosinophilia      prospective            among            count                 patient
                    hiv          therapy          patient                  member           patient                    used           highly        occlusion        treatment                   haart
               assessed       registered        underwent                 partner              mass              confidence             user              hiv            virus                     men
             resistance         pharmacy           effort                 success             virus                 mineral           showed               yr       univariate                pharmacy
                    art           sexual      biochemical                increase                mr                   known           member              hcv        suggested              associated
              important           family            owing               increased              cell                    care      spontaneous        injecting          patient                molecule
                   odds     asymptomatic            index              infiltrate    characteristic                    data            adult        frequency     metropolitan                   graft
               relevant         greatest     hypogonadism                 therapy         suggested                 english       peripheral        developed     respectively               presented
              influence             year        infection                   haart        outpatient                     aim          partner         elevated           female            transmission
              glycation          density       persistent                  result           partner                  effort       regression            human             play                  needed
                   long       persistent        occlusion               infection         collected                  change      requirement         assessed            china               potential
               modulate           needed            serum                   sleep             enter                   human             rate        secondary     complication                  better
                    pwh       introduced     respectively                  weight             owing                    gain         detailed          produce              aim                    idus
                 esrage        collected               cc                 content          occurred               phenotype        evaluated          history         baseline                   woman
                partner      composition     particularly               ethiopian          analysis                  higher       persistent          examine            count             established
             evaluation          concern             case                   graft           patient                   urban       population            count            human                   among
               impaired            viral         disorder                    harm          promotes               adherence             town              hcv              hiv                   virus
                   week        inventory       individual               collected           soluble                     age         previous              csf          suggest              prevalence
                  daily           factor           person             association          fumarate               elevation             cell             ivda              hiv              comparison
                    hiv        guideline            lipid                     low         potential               treatment       alteration        seventeen           higher               reporting
                   ivda              hiv             cell              coinfected           dietary                efficacy              aim             drug          picture               presented
                  rigid       evaluation         utilized                   viral       encouraging                     hiv             well         physical          program                analysis
         neurocognitive          patient            group               therefore         dimension                      ny              gay        hepatitis           impact                survival
                  daily      information       confidence                 therapy      demonstrated                 suggest             ivda         elevated           likely                 barrier
               clinical          subject           sexual                    late            partly                    bone       coinfected          patient        discussed               immigrant
               conflict             pwas          therapy                reported              rate                    pool          rapidly          regimen              gay         differentiation
                ability        treatment           change            multivariate           unclear               suggested        injection              car           condom                     hcv
              determine      qualitative         exposure                   count         tenofovir                    mass          placebo        presenter       associated                    risk
                  trial         previous    cerebrospinal                    side          changing                    poor            virus               ci    significantly             fcepsilonri
                   used      improvement          partner                    risk        individual                examined             week            fluid             lead                  health
                  human            study  differentiation                 patient        associated               evaluated           sexual          mansoni     demonstrated                 patient
             univariate           change           larger               expanding              area                   graft         efficacy         fumarate        treatment                   daily
                 immune     transmission      circumcised                   human             group                behavior            lipid       individual              one                logistic
                 little          symptom     longitudinal                economic        eosinophil                  muscle             risk       associated            focus             morphologic
              dimension              hiv           island                 failure           natural                  policy         majority        decreased            group               sustained
               although       cumulative         assessed               effective              late                   total             year             pwas             care                     hiv
             individual        infection       protection                   human       established              medication         infected           impact        immigrant            psychosocial
                however     presentation         baseline                    well             alter                  survey              aid      multicenter       alteration                   known
             increasing       consistent   susceptibility                     pwh            opiate               adherence          history            serum           cohort             significant
               function            adult      reinfection                    year               one                     use          dietary              bad           little                 chronic
              including         employed           cohort                   fluid             first               presenter             beta             many      susceptible                     men
                 versus           number            liver              eosinophil          promotes               glycation        treponema        indicated              art             biochemical
                utility     osteoporosis           factor                examined   methamphetamine                    week         syndrome              ass              azt                  former
            reinfection         compared             test                   human            policy               collected             life   rehabilitation      encouraging                 patient
                  graft            order    understanding                increase            energy               procedure          disease         compared             bone                 therapy
                    may            event         injected                    ivdu               aid                   virus         reported       eosinophil    epidemiologic          antiretroviral
             understand          disease     polymorphism                   adult         normative             institution        available             data           sought                  little
                patient           remain     investigated                 disease            person                  health         starting           people            adult            monoinfected
                support immunodeficiency              snp                practice         clearance              retroviral             harm             data      combination                acquired
              adherence     multivariate          despite             reinfection        coinfected               adherence          rapidly        clearance            srage                 barrier
                    art        clearance            count            testosterone              well                  result            total              aid           family               treatment
                   drug         proximal               le                  gender               low               sustained              std     transmission      reinfection             observation
                   ivda         examined     particularly               glycation                mg               sustained        addiction           policy          partner               developed
                 stigma           condom        increased               evaluated            factor                     use         disorder          symptom         clinical                  health
                 stigma           opiate              hcv                      ny               azt                survival            china           somali            daily                  common
             prostitute             ivda          picture                  dosage         infection               collected          regimen              car        increment                fumarate
              mortality              key         assessed                   total              city              employment          testing           washer           always               infection
                limited        adherence            known                 therapy              drug                pharmacy       evaluation           likely      maintaining                    mass
                 strain          regimen          overall                    idus            health               adherence   antiretroviral         interval          article                   abuse
                product        injecting         genotype             lipoprotein      quantifiable                      nk          capital         alveolar         proximal              individual
              treatment     hospitalized        injecting                   virus           without                  always           biopsy immunodeficiency         pharmacy                     azt
                patient       vocational           taking                     one               hcv              population   antiretroviral           change          therapy                    late
                  study          outcome          concern                     pwh              mass                     azt        injecting           sexual          symptom                 density
              morbidity       individual        increased                 patient           without                qoryoley       critically             type     transmission                     csf
              determine         frequent            ¦Ärage                  effect        consistent          characteristic         utilized          examine     particularly              persistent
              hepatitis             lean      transmitted                  factor             total                   haart             user       consistent            fluid                  unsafe
                partner              use             bone                     hcv       suppression            osteoporosis            human           lavage         although                utilized
               antibody       prevalence              azt                     hcv           regimen            inflammatory       coinfected      spontaneous      spontaneous               estimated
                 impact             male          therapy                    form            kenyan                 include           number   antiretroviral      spontaneous                     aid
             confidence             care       occasional                  effect               one                    ivdu            order        prognosis         fumarate                 finding
                    bal          routine          barrier                achieved             human                    rash      reinfection              hcv         analysis                    idus
                    hcv              csf         qoryoley                   srage          included               conducted          therapy           cohort            virus               injection
             coinfected           stable             cell           observational            highly                  little       individual       limitation             news               increased
         susceptibility     inflammatory           biopsy                   adult               men                  stress        adherence              low             type                    cell
                however            abuse         alveolar           significantly              male                employed immunodeficiency         genotype          service                  strain
                patient       individual      maintaining                   first        containing              individual     tolerability      formulating      requirement                  status
                   drug            srage   immunoglobulin             combination             asian                question             word              hdl       peripheral              nationwide
                   town          subject      fcepsilonri             schistosome      eosinophilia                   guide      association             pool       retroviral              deficiency
                    azt        mogadishu             care             reinfection           control              prevalence             said           marker          therapy            relationship
          epidemiologic          service             gain                research             cited                analysis           period           impact immunodeficiency               treatment
               promotes           washer        influence                  living           subject                    drug               ci       disoproxil    physiological              individual
                    use       nationwide      suppression               mogadishu              late               tenofovir              hiv      participant              rna                      nk
       immunophenotypic             ivda           review             experienced          disorder              government             year             show          barrier                      ci
               baseline        increased             drug                    drug        especially                 patient     transmission           status        adherence                evidence
               sexually         syndrome       meaningful                 patient         injecting                   study      encouraging              car       concerning                combined
               previous            ratio             cell              protective           subject                    cell        procedure         regional        elevation                 whether
                    bal        mortality          natural                   point             count                bisexual        sustained        determine            party               conducted
             associated           policy              hdl                  heroin         guideline               adherence           policy         relevant              hiv                provider
            fcepsilonri            known         greatest               receiving          behavior                  likely      involvement    cerebrospinal        immigrant                      nk
                  older             well         baseline                   viral             human                    late             drug      progression              rna                   count
               presence immunodeficiency            among                  plasma             liver                advanced   characteristic      suppression            virus                commonly
         cardiovascular     monoinfected      progression             participant             level               tenofovir              hiv             late              bal              individual
                    hiv        challenge        collected                    week               ass                   chain            owing       infiltrate            hdlox                   study
               baseline             life        presenter                     use           limited                  little        guideline          patient         discrete                 patency
                   male       coinfected           public                   human          computed                   viral           either           center              bad       electromyographic
                 living        describes      significant                    rash            somali                 partner          patient       containing           weight                    lean
                  level              bmd            chain                 inverse        population                distress           needed         eighteen           median                  median
            suppression  atherosclerotic           somali                increase    characteristic                genotype        potential            patch          therapy                     bmd
             persistent       alveolitis     respectively                efficacy          isolated              supporting             good        responder           health                practice
           relationship         presence       prevalence                     pyr              cell                 regimen        expressed        collected            first                distress
                   cell           showed         presence                   owing            person                  review         southern           member             town                genotype
                   male        hepatitis         abstract                   rural           density               including           stigma          therapy    multivariable                  family
                    ige             year              rna                      nk        moderately                    lead            month             load             bone              concerning
                   drug           subset          unclear                     hcv             study                utilized              hdl           others           island                    male
                dietary             data          barrier               treatment          pharmacy                    well         promotes     polymorphism       individual                 younger
             negligible        challenge          patient            testosterone       implication              infectious      antioxidant          fistula           sexual                   china
                  virus           taking    observational             spontaneous             virus                   major             mass             drug        reduction                 finding
                  daily            graft          ¦Äesrage             biochemical        durability               seventeen            score              new         achieved                      ci
                  serum          cleared         relevant                     bal              loss                     red          finding             rate            daily                     red
                  count              one          western                   level             graft                 mineral           scored         dialysis       individual            pathogenesis
                regimen           others       frequently                    role         describes                     aid          primary             bone             cell              evaluation
                patient           effect           reduce               proactive          antibody                    male           partly            score          outcome               infection
            distinctive         esoteric        objective                     rna            change                    role         designed           female             rate            investigated
                    hiv            guide         practice                 overall         correlate                  likely      maintaining   antiretroviral       prevalence                   found
                 change              hdl              std        immunodeficiency              rate                   fluid            among         distress            among                    well
             prevalence              hcv      formulating                   month              rash                   range      preexisting           either           better              eosinophil
              adherence            first              bmd              cumulative          reported                   level           somali           health          disease                 emerged
                     cc     transmission            maker       seroepidemiologic      polymorphism                receptor             need             user     monoinfected                    user
                   case          unknown             cell                    side               age                   chain            adult   antiretroviral       individual                   trial
            experienced            count             ivdu                  opiate        eosinophil                promotes            first     relationship        objective              infectious
                   drug        mortality         syndrome           significantly        macrophage             significant              hcv         analysis         weakness               mortality
polytetrafluoroethylene    opportunistic         behavior                  tissue           patient            particularly           member            rural        inventory                   graft
               genotype       associated            level            eosinophilia               bal             schistosome            serum              csf     relationship                  active
                   year         function       translated                   group               age                syndrome              ass        situation         disorder                     bal
              collected            group             week             established             virus               frequency            study             cell      subcategory            complication
        retrospectively        phenotype            study                analysis      asymptomatic                     pwh              mrr            prior           strong                 patient
                  count           factor            human             biochemical             model               prognosis         baseline   neurocognitive             beta                modulate
                    gay             bone         exposure                  factor           finding                category          chinese      coinfection          history               secretory
              injection        collected             care                      ci            social                 engaged        decreased     particularly             data                  sexual
                   year         positive        injecting                  versus         tenofovir             intercourse       individual       evaluation          however                  muscle
                   bone    opportunistic       respondent            metropolitan       reinfection              disoproxil        injection            study           social                assessed
                    low           random     monoinfected                 primary             human                   adult       medication        collected        treatment                 outcome
                 cohort          overall              csf              associated            center                   count             host        collected              azt polytetrafluoroethylene
            preexisting       translated              pwh             requirement           routine              alveolitis       homosexual          patient           review                baseline
               relevant              snp         compared                 patient               bal                  sexual        including        preceding         function             transmitted
           demonstrated            death       decreasing               performed        percentage                previous              std     investigated             thus                   hdlox
                chinese         previous         analyzed                  parent            status                   focus        objective         relevant            count                   heavy
                 health       macrophage             data                   fluid      hypogonadism                   among         modulate        ethnicity               le                  change
             covariates         analysis        treatment                 service             sleep          neurocognitive           marker           heroin           needed              protective
              adherence       increasing            least               adherence          function              occasional   reconstruction          reduced            viral                efficacy
                disease        mortality              red                  highly         resistant                 history         achieved             none             died               treatment
             population          regimen           esrage                 patient              mean                  thirst     longitudinal         research          barrier                  gender
                improve           people     eosinophilia                     bal         correlate                      nk          therapy         reported           sydney                alveolar
                 number       associated         presence                starting               hiv                  female          picture              car              red               prevalent
                concern            focus       alteration                 engaged                ci               increased              art              hiv        injecting                 require
                    age        infection             late                   among        identified             suppression        guideline          barrier   azidothymidine          azidothymidine
               estimate         distress          intense            relationship      hemodialysis            demonstrated          subject       evaluation         periodic                esoteric
         susceptibility           family         presence                     art             woman                    used         practice           policy        resistant               treponema
                related         alveolar           number                    pwas       spontaneous               adherence        indicated       especially            group          antiretroviral
                inverse    psychological          english                    lead              type                antibody         proximal           school   antiretroviral                reported
                utility         qoryoley            viral                 therapy           chinese                     aim            among        potential             drug               determine
              adherence             risk     polymorphism           participating           therapy                    ivda        addiction              men         although                  condom
              infection            human               le               presenter            immune                    drug            eight          without           killer             contributes
                 remain              hiv          patient                     hiv       fcepsilonri                     hcv             city              hiv            hdlox                      kg
               sexually     demonstrated             drug                   graft         operation               treatment        normative        potential       medication                     two
              decreased       consistent        responded                  public               use                  island            rural       population         clinical                  likely
                     ci             load            human                   major      transmission                    year          cleared       regression immunodeficiency                  weight
                   year         included             cell                     std              cell             suppression              hcv            total          patient                    risk
                    azt           common             rate              eosinophil               sex                distress         disorder        suggested               nk        immunodeficiency
                  adult          regimen        glycation                     ige               car                 whether            model           unsafe             cell                     six
           investigated   antiretroviral           factor          neurocognitive        translated              peripheral         starting          earlier              hcv            investigated
                measure          reduced      requirement                    week        associated                   adult          therapy            virus          natural                   guide
                  group         research          sibling                 patient             blood                     hdl           linked        injecting            alter                      mg
                failure              sex        increased               preceding           sibling              associated            adult             late       individual                survival
           undetectable           number        mortality                  people        decreasing         retrospectively       persistent               ci            viral                     age
                   skin            haart      biochemical                 sibling            family                    well       deficiency             drug       negligible               correlate
               clinical            entry          natural                  effect        clinically                      kg       macrophage             cell              csf                 regimen
                   long             rate             pool                  likely      asymptomatic                 ability              hcv        infection        increased                   fluid
                   mass         clinical           esrage               mogadishu        considered                  hunger            brief  retrospectively            haart                research
                   lean        injecting            entry                 subject              said             spontaneous            party       associated       alteration                    cell
                  liver   antiretroviral            issue            testosterone           provide                  factor            april           effect         periodic                 service
               practice         weakness             type               clearance               men               treatment        adherence            total        determine        coadministration
                    two              aim           policy                    bone          bisexual             significant         alveolar         analysis         disorder                   hdlox
                 muscle        estimated          program                 picture            period                  hunger            least       population         analyzed                   month
                  daily          without             lean              persistent      monoinfected           opportunistic       protection          patient             week                 kismayo
             ambulatory              hiv            count             implication            sexual                   group    questionnaire      reliability              azt               increased
                     df        developed            first               conducted           testing                   virus      biochemical             male          patient               seventeen
                 family            haart     respectively                   study    antiretroviral                 overall       individual            virus        determine                   brief
                   year        potential           muscle                   owing              ivdu               addiction     demonstrated              red       persistent               mortality
                 biopsy      lipoprotein           policy              considered             among                   china             ptfe           living        adherence               proactive
                  known          english           likely                    idus        persistent                dialysis           strong      significant       deficiency                  remain
                 status             type      suppression                although           therapy             qualitative              rna            group        dimension                     hcv
                   cell              bal   absorptiometry                    idus              data                 natural         computed        infection      multicenter                     hiv
                   late         increase        glycation              thrombosis         treatment               injecting         analysis         molecule           effect            hospitalized
               behavior             week            ratio                  former        understand                    body        objective         moreover        seventeen             encouraging
                 inject         clinical     metropolitan                     rna           however                     snp            urban              idu        dimension                   serum
           testosterone        therefore       frequently                 inverse           sibling              persistent            level         assessed        elevation                   virus
              treatment       medication             need                     hcv         correlate                 optimal          whereas           result       associated                clinical
                    pwh           thirst              six              evaluation           service                 capital              csf       occasional            ratio          cardiovascular
                    age     investigated         sexually                   range            others         methamphetamine          primary            eight       thrombosis                 antigen
              prevalent              key        infection                 cleared             human               normative         advanced          mineral         compared                   human
             percentage           likely            brief                    died     significantly            respectively           linked        operation      susceptible                  sexual
             respondent        immigrant        clearance               dimension         inventory                  person        suggested          opposed   antiretroviral                included
                    hcv          placebo             late             established        resistance                  living           sought          primary              art                  family
              objective       occurrence          regimen                  policy          baseline             coinfection        clinician       detectable             host                    idus